List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-12-09 21:33:20 | 136,180,481 0 | 136,180,481 | Form 13D |
| 2 | Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-12-09 21:33:20 | 136,180,481 0 | 136,180,481 | Form 13D |
| 3 | Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 2020-12-17 14:43:18 | 0 71,178,364 | 71,178,364 | Form 4 |
| 4 | DEBBANE RAYMOND Director | 2026-02-27 08:33:21 | 1,906,186 49,754,723 | 51,660,909 | Form 4 |
| 5 | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 2026-02-04 16:25:05 | 0 42,606,727 | 42,606,727 | Form 4 |
| 6 | MCNAIR ROBERT C 10% Owner | 2003-08-08 16:21:09 | 5,949,400 0 | 5,949,400 | Form 13D |
| 7 | Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner | 2022-08-09 16:48:13 | 331,545 5,451,204 | 5,782,749 | Form 4 |
| 8 | Invus C.V. Director 10% Owner | 2021-01-05 21:21:12 | 4,321,214 0 | 4,321,214 | Form 4 |
| 9 | SANDS ARTHUR T President & CEO | 2014-03-03 18:20:20 | 1,236,579 877,500 | 2,114,079 | Form 4 |
| 10 | Avicenna Life Sci Master Fund LP Avicenna Life Sci Master GP LLC Director 10% Owner | 2026-02-12 21:29:24 | 0 1,538,462 | 1,538,462 | Form 3 |
| 11 | COATS LONNEL Chief Executive Officer | 2024-02-29 16:26:53 | 1,430,198 0 | 1,430,198 | Form 4 |
| 12 | Exton Michael Chief Executive Officer | 2026-03-03 07:15:34 | 1,304,959 0 | 1,304,959 | Form 4 |
| 13 | Corrigan Brian SVP, Regulatory & QA | 2025-02-18 16:18:38 | 1,121,660 0 | 1,121,660 | Form 4 |
| 14 | Crum Brian T SVP, General Counsel & Secr. | 2026-03-03 07:17:13 | 838,516 0 | 838,516 | Form 4 |
| 15 | Granowitz Craig B SVP, Chief Medical Officer | 2026-03-03 07:19:33 | 802,177 0 | 802,177 | Form 4 |
| 16 | McDermott Wendy SVP, Human Resources | 2026-03-03 07:20:59 | 619,049 0 | 619,049 | Form 4 |
| 17 | MAIN ALAN J EVP, Innov & Chem Sciences | 2025-03-03 16:32:25 | 508,494 0 | 508,494 | Form 4 |
| 18 | Garner Thomas SVP, Chief Commercial Officer | 2024-02-12 16:14:04 | 454,260 0 | 454,260 | Form 4 |
| 19 | Coiante Scott M SVP, Chief Financial Officer | 2026-03-03 07:16:31 | 425,829 0 | 425,829 | Form 4 |
| 20 | Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Wittouck Amaury Director 10% Owner | 2026-02-19 16:50:12 | 0 408,435 | 408,435 | Form 4 |
| 21 | ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer | 2014-03-03 18:16:40 | 402,953 0 | 402,953 | Form 4 |
| 22 | DeFrancesco Lisa SVP, IR and Corp Comm | 2026-03-03 07:18:00 | 374,922 0 | 374,922 | Form 4 |
| 23 | WADE JEFFREY L President and COO | 2024-07-08 17:27:46 | 307,000 0 | 307,000 | Form 4 |
| 24 | Gopinathan Suma SVP, Discovery | 2026-03-03 07:18:43 | 301,722 0 | 301,722 | Form 4 |
| 25 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 2024-02-29 16:29:48 | 255,742 0 | 255,742 | Form 4 |
| 26 | BROWN PHILIP M SVP, Clinical Development | 2010-02-17 17:12:29 | 253,606 0 | 253,606 | Form 4 |
| 27 | BANSAL AJAY EVP Corp Dev and CFO | 2009-06-02 17:44:48 | 250,000 0 | 250,000 | Form 4 |
| 28 | TYLE PRAVEEN EVP, R&D | 2021-03-02 17:00:45 | 204,771 0 | 204,771 | Form 4 |
| 29 | SOBECKI CHRISTOPHER J Director | 2025-06-03 16:23:33 | 193,118 0 | 193,118 | Form 4 |
| 30 | Swain Judith L Director | 2025-06-03 16:25:29 | 193,118 0 | 193,118 | Form 4 |
| 31 | Amouyal Philippe Director | 2025-06-03 16:21:00 | 193,118 0 | 193,118 | Form 4 |
| 32 | Sullivan Diane E. Director | 2025-06-03 16:24:21 | 193,118 0 | 193,118 | Form 4 |
| 33 | BARKER SAM L Director | 2025-06-03 16:22:03 | 193,118 0 | 193,118 | Form 4 |
| 34 | Cheung Ivan Director | 2025-06-03 16:22:40 | 193,118 0 | 193,118 | Form 4 |
| 35 | RIGGS RANDALL B SVP, Corp Licensing | 2004-02-25 16:13:19 | 192,500 0 | 192,500 | Form 4 |
| 36 | Martens Rachel Yap SVP, Partnerships & Corp Strat | 2026-03-03 07:20:20 | 165,444 0 | 165,444 | Form 4 |
| 37 | GREGORY JULIA P EVP and CFO | 2008-02-11 18:05:27 | 150,000 0 | 150,000 | Form 4 |
| 38 | Alexander Kristen VP, Finance and Accounting | 2025-03-03 16:33:57 | 132,068 0 | 132,068 | Form 4 |
| 39 | Tessmer James F VP, Finance & Accounting | 2021-03-16 19:45:56 | 122,746 0 | 122,746 | Form 4 |
| 40 | Seth Kiernan VP, Chief Commercial Officer | 2023-03-01 16:55:29 | 104,350 0 | 104,350 | Form 4 |
| 41 | HOWSON TAMAR D EVP of Bus Dev | 2008-02-11 18:05:30 | 100,000 0 | 100,000 | Form 4 |
| 42 | Lapuerta Pablo EVP and CMO | 2020-04-24 17:02:57 | 85,719 0 | 85,719 | Form 4 |
| 43 | Tragash Steven Alan VP, Corporate Affairs | 2010-02-17 18:06:17 | 85,500 0 | 85,500 | Form 4 |
| 44 | LEFKOWITZ ROBERT J MD Director | 2024-05-13 16:03:08 | 81,716 0 | 81,716 | Form 4 |
| 45 | ISHIMOTO LANCE K SVP, Intellectual Property | 2008-02-11 18:05:33 | 80,000 0 | 80,000 | Form 4 |
| 46 | PERSON CHRISTOPHE VP Informatics | 2004-01-13 17:01:48 | 75,900 0 | 75,900 | Form 4 |
| 47 | SCHAFER CAROL VP Finance - Communications | 2003-12-10 15:01:46 | 61,000 0 | 61,000 | Form 3 |
| 48 | Santini Alexander A EVP and CCO | 2020-04-24 17:12:22 | 55,584 0 | 55,584 | Form 4 |
| 49 | PIGGOTT JAMES R PHD SVP of Pharm Bio | 2008-02-11 18:05:40 | 50,000 0 | 50,000 | Form 4 |
| 50 | NORTHCOTT JOHN VP, Marketing, Comm Strategy | 2015-03-03 16:08:14 | 41,985 0 | 41,985 | Form 4 |
| 51 | NIES ALAN S Director | 2023-05-22 16:05:20 | 41,046 0 | 41,046 | Form 4 |
| 52 | Palantoni Frank Director | 2023-05-22 16:06:07 | 40,332 0 | 40,332 | Form 4 |
| 53 | COLBERT WALTER F SVP, HR and Corp Serv | 2007-02-15 16:40:13 | 40,000 0 | 40,000 | Form 4 |
| 54 | ROSE CLAYTON STUART Director | 2007-06-27 16:34:13 | 25,000 0 | 25,000 | Form 4 |
| 55 | Wiltsey Kathleen M Director | 2009-04-27 16:40:25 | 10,000 0 | 10,000 | Form 4 |
| 56 | Mills Barry Director | 2007-04-27 16:35:38 | 10,000 0 | 10,000 | Form 4 |
| 57 | CLOHERTY PATRICIA M Director | 2006-04-28 17:58:27 | 10,000 0 | 10,000 | Form 4 |
| 58 | CASKEY C THOMAS Director | 2005-10-17 17:52:09 | 6,300 200 | 6,500 | Form 4 |